GLP-1 Key Research Facts Full name: Glucagon-Like Peptide-1 incretin hormone of the proglucagon family Primary bioactive form: GLP-1(736)amide 30 amino acids, C-terminally amidated Gene source: Proglucagon gene processed by PCSK1 in intestinal L-cells and brainstem NTS neurons In vivo half-life: Approximately 12 minutes rapidly inactivated by DPP-4 (cleaves His7-Ala8 dipeptide) Primary receptor: GLP-1R (GLP-1 receptor) class B G protein-coupled receptor (GPCR) Signalling: GLP-1R activation cAMP elevation PKA/CREB activation glucose-dependent insulin secretion Additional signalling: PI3K/Akt pathway -cell survival, proliferation, and glucose sensitivity Secretion pattern: Biphasic post-meal release from intestinal L-cells early neural/endocrine peak + late direct nutrient-contact peak Fasting plasma level: ~510 pmol/L
Many supplements combine both nutrients since deficiencies often occur together
While hyperbaric oxygen therapy has been established as a common method of oxygen delivery to wounds, it comes with challenges such as the high cost of treatments, limited indications for use and insurance reimbursement, claustrophobia, and travel time to facilities for lengthy daily therapy sessions
These effects are temporary and can sometimes be mitigated by staying hydrated and ensuring adequate nutrition
Schedule a Free Consultation The Medications We Offer In recent years, the landscape of medical weight loss has seen remarkable advancements, and we're thrilled to offer two groundbreaking options Semaglutide and Tirzepatide to our valued patients
